Innovation Payment (NUB), HTA & German Government-Sponsored Clinical Trials Webinar
Germany’s innovation payment (NUB) pathway has long been one of the most attractive routes in Europe for companies with products in the inpatient sector. But in recent years, its role has evolved — closely linking to HTA evaluations and, in some cases, government-sponsored clinical trials.
Join us to better understand how to leverage Germany’s NUB and HTA processes to support market access and evidence development.
🎤 Speakers
🗓 Event Details
Date & Time: Tuesday, October 14, 2025 — 16:00 to 17:00 CET